Publication | Open Access
Electrophysiological effects of a new class III antiarrhythmic agent (E-4031) on the conduction and refractoriness of the in vivo human atrium
15
Citations
0
References
1993
Year
These results suggest that E-4031 has a potential effect in the treatment of human paroxysmal atrial fibrillation.